E-learning TB course from WHO

As new WHO guidelines and operational guidance become available, new resources will be added and existing courses updated to enhance learning.

  1. Course name: Rapid diagnostics for tuberculosis detection


  • Explain the rationale for delivering diagnostic services and illustrate the key components and organization of a TB diagnostic network in different settings;
  • Describe the steps to be implemented when introducing a new diagnostic tool into an existing laboratory network;
  • Describe the TB diagnostic algorithms that incorporate the most recent WHO recommendations for detecting TB and DR-TB and outline considerations needed to be made for the implementation these new algorithms;
  • Explain indicators and targets and interpret results for performance monitoring of the laboratory network.

Register here: Rapid diagnostics for tuberculosis detection


  1. Course name: Tuberculosis preventive treatment


  • Explain the elements of a system for implementing and scaling up TB preventive treatment, including the platforms and mechanisms necessary for policy development, decision-making and resource mobilization;
  • Describe the cascade of care for TB preventive treatment and the components of TB preventive treatment programmes necessary for identifying people at risk, offering appropriate regimens and supporting them in overcoming barriers to complete treatment;
  • Define the main indicators of the performance of TB preventive treatment and explain how to calculate and interpret them.

Register here: Tuberculosis preventive treatment


  1. Course name: Drug-resistant tuberculosis treatment


  • Select the appropriate treatment regimen for drug-resistant TB (shorter or longer) for eligible patient groups, taking into consideration the needs of various subgroups, the country context, epidemiological background, patient’s history and results of drug-susceptibility testing;
  • Explain the implementation considerations for different regimens for eligible patient groups, adjunctive treatment and the active TB drug safety monitoring and management framework (known as aDSM);
  • Analyse and interpret key indicators of drug-resistant TB and explain how to assess the effectiveness of treatment of drug-resistant TB through cohort analysis.

Register here: Drug-resistant tuberculosis treatment